Quantcast

Latest Fondaparinux Stories

2014-09-10 08:29:40

Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Ireland Limited has entered into an agreement to acquire the U.S. commercialization, marketing and intellectual property rights relating to Arixtra® (fondaparinux sodium) Injection and the authorized generic (AG) of Arixtra from Aspen Global Incorporated. Arixtra...

2011-07-07 15:10:18

Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an inferior vena cava filter (IVCF) to the anticoagulant medication fondaparinux (Arixtra), according to research presented today at the 14th World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer. "This is the first prospective study to evaluate the...

2011-01-24 14:42:00

RESEARCH TRIANGLE PARK, N.C., Jan. 24, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) has become aware of a United States market recall of all lots of alcohol prep pads, swabs and swabsticks manufactured by the Triad Group and marketed under various brand names. The Triad Group recall has been initiated due to concerns about potential microbial contamination of the alcohol products with Bacillus cereus that could potentially lead to life-threatening infections. Some of these alcohol prep pads...

2010-09-02 08:46:25

(Ivanhoe Newswire) "“ Many coronary procedures are done every year, and many involve the use of Heparin, an anticoagulant which prevents the blood from clotting and forming harmful bigger clots in the veins and arteries. It is typically used in lower doses for patients getting coronary procedures, but this study shows that using lower doses isn't more effective than using normal dosage. Patients with acute coronary syndrome initially treated with Fondaparinux, an anticoagulant which...

2010-08-31 20:33:20

Patients with acute coronary syndromes initially treated with the anticoagulant fondaparinux who underwent a coronary procedure (such as balloon angioplasty) and received a lower dose of the anticoagulant heparin during the procedure did not have a reduced rate of major bleeding and vascular access site complications, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of...

2010-08-31 20:29:37

A landmark international study, coordinated by McMaster University, has found that lower doses of a blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux. In a prior study, the OASIS 5 trial, researchers from McMaster University showed that a blood thinner fondaparinux compared to another blood thinner, enoxaparin, reduced serious...

2008-08-22 03:00:10

By Fareed, J Iqbal, O; Cunanan, J; Demir, M; Wahi, R; Clarke, M; Adiguzel, C; Bick, R The conventional management of thrombotic and cardiovascular disorders is based on the use of heparin, oral anticoagulants and aspirin. Despite progress in the sciences, these drugs still remain a challenge and mystery. The development of low molecular weight heparins (LMWHS) and the synthesis of heparinomimetics represent a refined use of heparin. Additional drugs will continue to develop. However, none...

82aabbb7e29431fd90f263e4a1791851
2008-04-02 06:05:00

Chopped pig pancreas may not sound appetizing. But most cystic fibrosis patients eat a refined version of it each breakfast, lunch and dinner - five large capsules a meal - to supply enzymes that their bodies do not produce. The pills are life-sustaining for most of the nearly 30,000 people in the United States with cystic fibrosis, a hereditary disease that attacks the lungs and digestive tract. But partly because of the drug's source there have been longstanding concerns about those...

2006-03-14 14:15:08

By Deena Beasley ATLANTA (Reuters) - Heart attack patients treated with anti-thrombosis drugs instead of the blood-thinner heparin are less likely to die or have another heart attack, researchers told a meeting of cardiologists on Tuesday. "This is a better blood-thinning strategy for patients who have a heart attack," said Harvard Medical School professor Dr. Elliott Antman, lead investigator of the trial comparing the drug Lovenox to heparin. Lovenox, sold by France's Sanofi...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related